Cargando…

Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective

Giant cell arteritis, a common primary systemic vasculitis affecting older people, presents acutely as a medical emergency and requires rapid specialist assessment and treatment to prevent irreversible vision loss. Disruption of the health-care system caused by the COVID-19 pandemic exposed weak poi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mackie, Sarah L, Brouwer, Elisabeth, Conway, Richard, van der Geest, Kornelis S M, Mehta, Puja, Mollan, Susan P, Neill, Lorna, Putman, Michael, Robinson, Philip C, Sattui, Sebastian E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834492/ https://www.ncbi.nlm.nih.gov/pubmed/33521671 http://dx.doi.org/10.1016/S2665-9913(20)30386-6

Ejemplares similares

Diagnostic Accuracy of Symptoms, Physical Signs, and Laboratory Tests for Giant Cell Arteritis: A Systematic Review and Meta-analysis
por: van der Geest, Kornelis S. M., et al.
Publicado: (2020)

Need and value of targeted immunosuppressive therapy in giant cell arteritis
por: Sandovici, Maria, et al.
Publicado: (2022)

Benchmarking tocilizumab use for giant cell arteritis
por: Conway, Richard, et al.
Publicado: (2022)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Decreased Immunity to Varicella Zoster Virus in Giant Cell Arteritis
por: Rondaan, Christien, et al.
Publicado: (2017)

Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis
por: van Sleen, Yannick, et al.
Publicado: (2017)

Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica
por: Reitsema, Rosanne D., et al.
Publicado: (2023)

Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2019)

Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis
por: van Sleen, Yannick, et al.
Publicado: (2019)

Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica
por: van der Geest, Kornelis S. M., et al.
Publicado: (2022)

Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment
por: Esen, Idil, et al.
Publicado: (2021)

Role of the halo sign in the assessment of giant cell arteritis: a systematic review and meta-analysis
por: Sebastian, Alwin, et al.
Publicado: (2021)

Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization
por: Stellingwerff, Menno D., et al.
Publicado: (2015)

Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?
por: van der Geest, Kornelis S. M., et al.
Publicado: (2018)

Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8(+) T cells in giant cell arteritis
por: Reitsema, Rosanne D, et al.
Publicado: (2022)

Giant cell arteritis: reviewing the advancing diagnostics and management
por: Bilton, Edward J., et al.
Publicado: (2023)

Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2022)

Profile of tocilizumab and its potential in the treatment of giant cell arteritis
por: Mollan, Susan Patricia, et al.
Publicado: (2018)

Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss
por: van der Geest, Kornelis S. M., et al.
Publicado: (2020)

A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL‐40/Interleukin‐13 Receptor α2 Axis
por: van Sleen, Yannick, et al.
Publicado: (2021)

Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2022)

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia
por: van der Geest, Kornelis S M, et al.
Publicado: (2020)

Giant cell arteritis complicated by acute pancreatitis: a case report
por: Seneviratne, Deepthi Renuka, et al.
Publicado: (2008)

Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis
por: Al-Mousawi, Alia Z., et al.
Publicado: (2019)

Response to ‘Comment on: ‘A new era for giant cell arteritis’’
por: Mollan, S. P., et al.
Publicado: (2019)

Distinct macrophage phenotypes skewed by local granulocyte macrophage colony‐stimulating factor (GM‐CSF) and macrophage colony‐stimulating factor (M‐CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis
por: Jiemy, William F, et al.
Publicado: (2020)

Halo score (temporal artery, its branches and axillary artery) as a diagnostic, prognostic and disease monitoring tool for Giant Cell Arteritis (GCA)
por: Sebastian, Alwin, et al.
Publicado: (2020)

European Headache Federation recommendations for neurologists managing giant cell arteritis
por: Mollan, S. P., et al.
Publicado: (2020)

Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021)

Current advances in the treatment of giant cell arteritis: the role of biologics
por: Low, Candice, et al.
Publicado: (2019)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Treatment failure in giant cell arteritis
por: Unizony, Sebastian H, et al.
Publicado: (2021)

Penile Squamous Cell Carcinoma Masquerading as Giant Condyloma
por: Hassid, Victor J., et al.
Publicado: (2017)

Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica
por: Low, Candice, et al.
Publicado: (2023)

Implementation: The Next Giant Hurdle to Clinical Transformation With Digital Health
por: Buis, Lorraine
Publicado: (2019)

Diagnostic value of axillary artery ultrasound in patients with suspected giant cell arteritis
por: Hop, Hilde, et al.
Publicado: (2020)

Giant Lipoma of the Back Caused Compression Fracture of the Thoracic Vertebral Bones
por: Kino, Hiromi, et al.
Publicado: (2019)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

Updates on the diagnosis and monitoring of giant cell arteritis
por: Monti, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a58ae35g9mn71fa1r5u0eq4pgo